BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 5221345)

  • 1. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
    Foldes FF; Smith JC
    Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE
    Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the treatment of myasthenia].
    Delwaide JP
    Rev Med Liege; 1968 Sep; 23(18):552-7. PubMed ID: 4316587
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F
    Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of myasthenia gravis.
    Flacke W
    N Engl J Med; 1973 Jan; 288(1):27-31. PubMed ID: 4347296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapetic measures in myasthenia gravis].
    Cavaciuti P; Gatti E
    Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis and glycopyrrolate.
    Marcus E; Wayne F
    S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current trends in medical and surgical treatment of myasthenia gravis with persistence of the thymus and long-term results of some operated cases].
    Sunseri S; Sottosanti M; Spinelli P
    Arch Chir Torac Cardiovasc; 1970; 26(1):19-34. PubMed ID: 5477673
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholinesterase inhibitors in myasthenia gravis.
    Lange MJ
    Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis and pregnancy.
    Chambers DC; Hall JE; Boyce J
    Obstet Gynecol; 1967 Apr; 29(4):597-603. PubMed ID: 6067025
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of myasthenia. II.
    Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis focal to the larynx. Report of a case.
    Neiman RF; Mountjoy JR; Allen EL
    Arch Otolaryngol; 1975 Sep; 101(9):569-70. PubMed ID: 1164241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-varicella myasthenia gravis.
    Saha A; Batra P; Vilhekar KY; Chaturvedi P
    Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW
    Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apropos of myasthenia gravis and its treatment].
    Leroy J; Robert M; Delaunay P; Dordain M
    Sem Hop; 1969 May; 45(24):1691-3. PubMed ID: 4308561
    [No Abstract]   [Full Text] [Related]  

  • 20. MANAGEMENT OF MYASTHENIA GRAVIS IN THE OBSTETRICAL PATIENT.
    MCNALL PG; JAFARNIA MR
    Am J Obstet Gynecol; 1965 Jun; 92():518-25. PubMed ID: 14295887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.